Extracorporeal life support after heart or lung transplantation

Extracorporeal life support (ECLS) has been used in 10 patients after heart (5 patients), lung (3 patients), and heart-lung (2 patients) transplantation. The age range was 7 months to 55 years. Cardiopulmonary failure leading to institution of ECLS was due to acute postoperative organ malfunction in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 1994-09, Vol.58 (3), p.754-758
Hauptverfasser: Whyte, Richard I., Deeb, G.Michael, McCurry, Kenneth R., Anderson, Harry L., Boiling, Steven F., Bartlett, Robert H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 758
container_issue 3
container_start_page 754
container_title The Annals of thoracic surgery
container_volume 58
creator Whyte, Richard I.
Deeb, G.Michael
McCurry, Kenneth R.
Anderson, Harry L.
Boiling, Steven F.
Bartlett, Robert H.
description Extracorporeal life support (ECLS) has been used in 10 patients after heart (5 patients), lung (3 patients), and heart-lung (2 patients) transplantation. The age range was 7 months to 55 years. Cardiopulmonary failure leading to institution of ECLS was due to acute postoperative organ malfunction in 4 patients (2 survived), subacute organ malfunction in 3 patients (none survived), and late rejection or infection in 3 patients (2 survived). Neurologic complications occurred in 3 patients (1 survived) and bleeding, in 5 patients (2 survived). Six patients (60%) were successfully weaned from ECLS, and 4 (40%) survived to leave the hospital. Survival was associated with younger age, shorter duration of ECLS, and longer interval from operation to initiation of ECLS but not to reason for initiating ECLS. Extracorporeal life support is feasible for sustaining both adults and children after heart, lung, or heart-lung transplantation. Best results were obtained in patients with conditions that, in retrospect, were treatable and reversible within days. More experience is needed to predict preoperatively which patients will benefit most from ECLS.
doi_str_mv 10.1016/0003-4975(94)90741-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76778899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0003497594907412</els_id><sourcerecordid>76778899</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-1cb7dc0f45eba34263bcd52deb09ff50ffd77ef6605a2224e1f2c9a9e89c721a3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EKqXwByBlhWARsB07jjcgVJWHVIkNrC3HGYNRmgTbQfD3uLTqktXM6N55HYROCb4imJTXGOMiZ1LwC8kuJRaM5HQPTQnnNC8pl_tourMcoqMQPlJJkzxBEyEZK6WcotvFd_Ta9H7oPeg2a52FLIxDKmOmbQSfvYNOee-zduzesuTuwtDqLuro-u4YHVjdBjjZxhl6vV-8zB_z5fPD0_xumRtWVDEnphaNwZZxqHXBaFnUpuG0gRpLazm2thECbFlirimlDIilRmoJlTSCEl3M0Plm7uD7zxFCVCsXDLTpEOjHoEQpRFVJmYxsYzS-D8GDVYN3K-1_FMFqzU2toag1FCWZ-uOmaGo7284f6xU0u6YtqKTfbHRIT3458CoYB52BxnkwUTW9-3_BLyKhfa4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76778899</pqid></control><display><type>article</type><title>Extracorporeal life support after heart or lung transplantation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Whyte, Richard I. ; Deeb, G.Michael ; McCurry, Kenneth R. ; Anderson, Harry L. ; Boiling, Steven F. ; Bartlett, Robert H.</creator><creatorcontrib>Whyte, Richard I. ; Deeb, G.Michael ; McCurry, Kenneth R. ; Anderson, Harry L. ; Boiling, Steven F. ; Bartlett, Robert H.</creatorcontrib><description>Extracorporeal life support (ECLS) has been used in 10 patients after heart (5 patients), lung (3 patients), and heart-lung (2 patients) transplantation. The age range was 7 months to 55 years. Cardiopulmonary failure leading to institution of ECLS was due to acute postoperative organ malfunction in 4 patients (2 survived), subacute organ malfunction in 3 patients (none survived), and late rejection or infection in 3 patients (2 survived). Neurologic complications occurred in 3 patients (1 survived) and bleeding, in 5 patients (2 survived). Six patients (60%) were successfully weaned from ECLS, and 4 (40%) survived to leave the hospital. Survival was associated with younger age, shorter duration of ECLS, and longer interval from operation to initiation of ECLS but not to reason for initiating ECLS. Extracorporeal life support is feasible for sustaining both adults and children after heart, lung, or heart-lung transplantation. Best results were obtained in patients with conditions that, in retrospect, were treatable and reversible within days. More experience is needed to predict preoperatively which patients will benefit most from ECLS.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/0003-4975(94)90741-2</identifier><identifier>PMID: 7944699</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age Factors ; Cardiopulmonary Resuscitation - methods ; Cardiopulmonary Resuscitation - mortality ; Catheterization, Central Venous ; Catheters, Indwelling ; Child ; Child, Preschool ; Extracorporeal Circulation ; Female ; Follow-Up Studies ; Heart Transplantation ; Heart-Lung Transplantation ; Humans ; Infant ; Life Support Care - methods ; Lung Transplantation ; Male ; Middle Aged ; Postoperative Care ; Postoperative Complications - mortality ; Postoperative Complications - therapy ; Retrospective Studies ; Survival Rate ; Time Factors</subject><ispartof>The Annals of thoracic surgery, 1994-09, Vol.58 (3), p.754-758</ispartof><rights>1994 The Society of Thoracic Surgeons</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-1cb7dc0f45eba34263bcd52deb09ff50ffd77ef6605a2224e1f2c9a9e89c721a3</citedby><cites>FETCH-LOGICAL-c438t-1cb7dc0f45eba34263bcd52deb09ff50ffd77ef6605a2224e1f2c9a9e89c721a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7944699$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whyte, Richard I.</creatorcontrib><creatorcontrib>Deeb, G.Michael</creatorcontrib><creatorcontrib>McCurry, Kenneth R.</creatorcontrib><creatorcontrib>Anderson, Harry L.</creatorcontrib><creatorcontrib>Boiling, Steven F.</creatorcontrib><creatorcontrib>Bartlett, Robert H.</creatorcontrib><title>Extracorporeal life support after heart or lung transplantation</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Extracorporeal life support (ECLS) has been used in 10 patients after heart (5 patients), lung (3 patients), and heart-lung (2 patients) transplantation. The age range was 7 months to 55 years. Cardiopulmonary failure leading to institution of ECLS was due to acute postoperative organ malfunction in 4 patients (2 survived), subacute organ malfunction in 3 patients (none survived), and late rejection or infection in 3 patients (2 survived). Neurologic complications occurred in 3 patients (1 survived) and bleeding, in 5 patients (2 survived). Six patients (60%) were successfully weaned from ECLS, and 4 (40%) survived to leave the hospital. Survival was associated with younger age, shorter duration of ECLS, and longer interval from operation to initiation of ECLS but not to reason for initiating ECLS. Extracorporeal life support is feasible for sustaining both adults and children after heart, lung, or heart-lung transplantation. Best results were obtained in patients with conditions that, in retrospect, were treatable and reversible within days. More experience is needed to predict preoperatively which patients will benefit most from ECLS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Cardiopulmonary Resuscitation - methods</subject><subject>Cardiopulmonary Resuscitation - mortality</subject><subject>Catheterization, Central Venous</subject><subject>Catheters, Indwelling</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Extracorporeal Circulation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Transplantation</subject><subject>Heart-Lung Transplantation</subject><subject>Humans</subject><subject>Infant</subject><subject>Life Support Care - methods</subject><subject>Lung Transplantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Postoperative Care</subject><subject>Postoperative Complications - mortality</subject><subject>Postoperative Complications - therapy</subject><subject>Retrospective Studies</subject><subject>Survival Rate</subject><subject>Time Factors</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EKqXwByBlhWARsB07jjcgVJWHVIkNrC3HGYNRmgTbQfD3uLTqktXM6N55HYROCb4imJTXGOMiZ1LwC8kuJRaM5HQPTQnnNC8pl_tourMcoqMQPlJJkzxBEyEZK6WcotvFd_Ta9H7oPeg2a52FLIxDKmOmbQSfvYNOee-zduzesuTuwtDqLuro-u4YHVjdBjjZxhl6vV-8zB_z5fPD0_xumRtWVDEnphaNwZZxqHXBaFnUpuG0gRpLazm2thECbFlirimlDIilRmoJlTSCEl3M0Plm7uD7zxFCVCsXDLTpEOjHoEQpRFVJmYxsYzS-D8GDVYN3K-1_FMFqzU2toag1FCWZ-uOmaGo7284f6xU0u6YtqKTfbHRIT3458CoYB52BxnkwUTW9-3_BLyKhfa4</recordid><startdate>19940901</startdate><enddate>19940901</enddate><creator>Whyte, Richard I.</creator><creator>Deeb, G.Michael</creator><creator>McCurry, Kenneth R.</creator><creator>Anderson, Harry L.</creator><creator>Boiling, Steven F.</creator><creator>Bartlett, Robert H.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940901</creationdate><title>Extracorporeal life support after heart or lung transplantation</title><author>Whyte, Richard I. ; Deeb, G.Michael ; McCurry, Kenneth R. ; Anderson, Harry L. ; Boiling, Steven F. ; Bartlett, Robert H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-1cb7dc0f45eba34263bcd52deb09ff50ffd77ef6605a2224e1f2c9a9e89c721a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Cardiopulmonary Resuscitation - methods</topic><topic>Cardiopulmonary Resuscitation - mortality</topic><topic>Catheterization, Central Venous</topic><topic>Catheters, Indwelling</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Extracorporeal Circulation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Transplantation</topic><topic>Heart-Lung Transplantation</topic><topic>Humans</topic><topic>Infant</topic><topic>Life Support Care - methods</topic><topic>Lung Transplantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Postoperative Care</topic><topic>Postoperative Complications - mortality</topic><topic>Postoperative Complications - therapy</topic><topic>Retrospective Studies</topic><topic>Survival Rate</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whyte, Richard I.</creatorcontrib><creatorcontrib>Deeb, G.Michael</creatorcontrib><creatorcontrib>McCurry, Kenneth R.</creatorcontrib><creatorcontrib>Anderson, Harry L.</creatorcontrib><creatorcontrib>Boiling, Steven F.</creatorcontrib><creatorcontrib>Bartlett, Robert H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whyte, Richard I.</au><au>Deeb, G.Michael</au><au>McCurry, Kenneth R.</au><au>Anderson, Harry L.</au><au>Boiling, Steven F.</au><au>Bartlett, Robert H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracorporeal life support after heart or lung transplantation</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>1994-09-01</date><risdate>1994</risdate><volume>58</volume><issue>3</issue><spage>754</spage><epage>758</epage><pages>754-758</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><abstract>Extracorporeal life support (ECLS) has been used in 10 patients after heart (5 patients), lung (3 patients), and heart-lung (2 patients) transplantation. The age range was 7 months to 55 years. Cardiopulmonary failure leading to institution of ECLS was due to acute postoperative organ malfunction in 4 patients (2 survived), subacute organ malfunction in 3 patients (none survived), and late rejection or infection in 3 patients (2 survived). Neurologic complications occurred in 3 patients (1 survived) and bleeding, in 5 patients (2 survived). Six patients (60%) were successfully weaned from ECLS, and 4 (40%) survived to leave the hospital. Survival was associated with younger age, shorter duration of ECLS, and longer interval from operation to initiation of ECLS but not to reason for initiating ECLS. Extracorporeal life support is feasible for sustaining both adults and children after heart, lung, or heart-lung transplantation. Best results were obtained in patients with conditions that, in retrospect, were treatable and reversible within days. More experience is needed to predict preoperatively which patients will benefit most from ECLS.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>7944699</pmid><doi>10.1016/0003-4975(94)90741-2</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4975
ispartof The Annals of thoracic surgery, 1994-09, Vol.58 (3), p.754-758
issn 0003-4975
1552-6259
language eng
recordid cdi_proquest_miscellaneous_76778899
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adolescent
Adult
Age Factors
Cardiopulmonary Resuscitation - methods
Cardiopulmonary Resuscitation - mortality
Catheterization, Central Venous
Catheters, Indwelling
Child
Child, Preschool
Extracorporeal Circulation
Female
Follow-Up Studies
Heart Transplantation
Heart-Lung Transplantation
Humans
Infant
Life Support Care - methods
Lung Transplantation
Male
Middle Aged
Postoperative Care
Postoperative Complications - mortality
Postoperative Complications - therapy
Retrospective Studies
Survival Rate
Time Factors
title Extracorporeal life support after heart or lung transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T10%3A38%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracorporeal%20life%20support%20after%20heart%20or%20lung%20transplantation&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Whyte,%20Richard%20I.&rft.date=1994-09-01&rft.volume=58&rft.issue=3&rft.spage=754&rft.epage=758&rft.pages=754-758&rft.issn=0003-4975&rft.eissn=1552-6259&rft_id=info:doi/10.1016/0003-4975(94)90741-2&rft_dat=%3Cproquest_cross%3E76778899%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76778899&rft_id=info:pmid/7944699&rft_els_id=0003497594907412&rfr_iscdi=true